Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""ISCHEMIC stroke"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 21-40 z 72209
Tytuł:
Association between serum triglycerides and stroke type, severity, and prognosis. Analysis in 6558 patients.
Autorzy:
Akhtar N; Hamad Medical Corporation, Neurology, North Tower, Doha, Qatar.
Singh R; Hamad Medical Corporation, Neurology, North Tower, Doha, Qatar.
Kamran S; Hamad Medical Corporation, Neurology, North Tower, Doha, Qatar.
Joseph S; Hamad Medical Corporation, Neurology, North Tower, Doha, Qatar.
Morgan D; Hamad Medical Corporation, Neurology, North Tower, Doha, Qatar.
Uy RT; Hamad Medical Corporation, Neurology, North Tower, Doha, Qatar.
Treit S; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Shuaib A; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. .
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2024 Mar 05; Vol. 24 (1), pp. 88. Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:
Journal Article
MeSH Terms:
Ischemic Stroke*
Stroke*/epidemiology
Diabetes Mellitus*
Humans ; Male ; Adult ; Middle Aged ; Aged ; Cross-Sectional Studies ; Prospective Studies ; Retrospective Studies ; Prognosis ; Obesity ; Triglycerides
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Understanding the Pathophysiology of Ischemic Stroke: The Basis of Current Therapies and Opportunity for New Ones.
Autorzy:
Salaudeen MA; Division of Neuroscience, Faculty of Biology, Medicine and Health, School of Biological Sciences, University of Manchester, Manchester M13 9PL, UK.; Department of Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Ahmadu Bello University, Zaria 810107, Nigeria.
Bello N; Department of Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Ahmadu Bello University, Zaria 810107, Nigeria.; Department of Pharmacology and Therapeutics, Faculty of Clinical Sciences, College of Health Sciences, Usmanu Danfodiyo University, Sokoto 840001, Nigeria.
Danraka RN; Department of Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Ahmadu Bello University, Zaria 810107, Nigeria.
Ammani ML; Department of Biosciences, School of Science and Technology, Nottingham Trent University, Nottingham NG11 8NS, UK.; Department of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, Kaduna State University, Kaduna 800283, Nigeria.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2024 Mar 04; Vol. 14 (3). Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Brain Ischemia*/drug therapy
Ischemic Stroke*/drug therapy
Stroke*/drug therapy
Neuroprotective Agents*/therapeutic use
Humans ; Cell- and Tissue-Based Therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Elevation of astrocyte-derived extracellular vesicles over the first month post-stroke in humans.
Autorzy:
Edwardson MA; Department of Neurology, Georgetown University, Washington, DC, USA. .; Research Division, MedStar National Rehabilitation Hospital, Washington, DC, USA. .
Mitsuhashi M; NanoSomiX, Inc., Irvine, CA, USA.
Van Epps D; NanoSomiX, Inc., Irvine, CA, USA.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 04; Vol. 14 (1), pp. 5272. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:
Journal Article
MeSH Terms:
Stroke*
Ischemic Stroke*
Extracellular Vesicles*
Humans ; Astrocytes ; Brain
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Relationship between glycated hemoglobin levels and three-month outcomes in acute ischemic stroke patients with or without diabetes: a prospective Korean cohort study.
Autorzy:
Cao C; Department of Rehabilitation, Shenzhen Dapeng New District Nan'ao People's Hospital, No. 6, Renmin Road, Dapeng New District, Shenzhen, 518000, Guangdong Province, China.; Department of Rehabilitation, Futian District, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, No.3002, Sungang West Road, Shenzhen, 518000, Guangdong Province, China.
Wang TB; Skidmore College, 815 North Broadway, Mailbox 8411, Saratoga Spring, NY, 12866-1632, USA.
Hu H; Department of Nephrology, Futian District, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, No.3002, Sungang West Road, Shenzhen, 518000, Guangdong Province, China.
Han Y; Department of Nephrology, Futian District, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, No.3002, Sungang West Road, Shenzhen, 518000, Guangdong Province, China. .; Department of Emergency, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518000, Guangdong Province, China. .
Zhang X; Department of Rehabilitation, Shenzhen Dapeng New District Nan'ao People's Hospital, No. 6, Renmin Road, Dapeng New District, Shenzhen, 518000, Guangdong Province, China. .
Wang Y; Department of Rehabilitation, Futian District, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, No.3002, Sungang West Road, Shenzhen, 518000, Guangdong Province, China. .
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2024 Mar 04; Vol. 24 (1), pp. 85. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:
Journal Article
MeSH Terms:
Ischemic Stroke*
Diabetes Mellitus*/epidemiology
Humans ; Cohort Studies ; Glycated Hemoglobin ; Prospective Studies ; Republic of Korea/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Optimization Design of Macrophage Membrane Camouflaging Liposomes for Alleviating Ischemic Stroke Injury through Intranasal Delivery.
Autorzy:
Liu T; School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China.
Wang Y; School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China.
Zhang M; School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China.
Zhang J; School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China.
Kang N; School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China.
Zheng L; School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China.
Ding Z; School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 02; Vol. 25 (5). Date of Electronic Publication: 2024 Mar 02.
Typ publikacji:
Journal Article
MeSH Terms:
Ischemic Stroke*
Saponins*/pharmacology
Rats ; Animals ; Liposomes/chemistry ; Endothelial Cells ; Administration, Intranasal ; Macrophages
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Serum heme oxygenase-1 level predicts clinical outcome after acute ischemic stroke.
Autorzy:
Wang H; Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.; Center of Cerebrovascular Diseases, West China Hospital, Sichuan University, Chengdu, China.
Cui T; Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.; Center of Cerebrovascular Diseases, West China Hospital, Sichuan University, Chengdu, China.
Chen Y; Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.; Center of Cerebrovascular Diseases, West China Hospital, Sichuan University, Chengdu, China.
Chen M; Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.; Center of Cerebrovascular Diseases, West China Hospital, Sichuan University, Chengdu, China.
Zhang S; Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.; Center of Cerebrovascular Diseases, West China Hospital, Sichuan University, Chengdu, China.
Leng X; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.
Wang D; Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.; Center of Cerebrovascular Diseases, West China Hospital, Sichuan University, Chengdu, China.
Pokaż więcej
Źródło:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Mar; Vol. 30 (3), pp. e14701.
Typ publikacji:
Journal Article
MeSH Terms:
Ischemic Stroke*/complications
Stroke*/complications
Brain Ischemia*
Humans ; Biomarkers ; Heme Oxygenase-1 ; Prognosis ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Malignancy-associated ischemic stroke: Implications for diagnostic and therapeutic workup.
Autorzy:
Xie W; Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Hsu S; Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Lin Y; Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xie L; Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jin X; Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhu Z; Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Guo Y; Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Chen C; Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Huang D; Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Boltze J; School of Life Sciences, University of Warwick, Coventry, UK.
Li P; Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Clinical Research Center, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Outcomes Research Consortium, Cleveland, Ohio, USA.
Pokaż więcej
Źródło:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Mar; Vol. 30 (3), pp. e14619.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Ischemic Stroke*/complications
Neoplasms*/complications
Stroke*/complications
Humans ; Risk Factors ; Neuroimaging
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Benefit of endovascular treatment for primary versus secondary medium vessel occlusion: A multi-center experience.
Autorzy:
Hu HZ; Department of Neurology, General Hospital of Northern Theater Command, Shenyang, China.; Department of Graduate School, China Medical University, Shenyang, China.
Zhao YG; Department of Neurology, General Hospital of Northern Theater Command, Shenyang, China.
Liu X; Department of Neurology, General Hospital of Northern Theater Command, Shenyang, China.
Sun XH; Department of Neurology, General Hospital of Northern Theater Command, Shenyang, China.
Nguyen TN; Neurology, Radiology, Boston Medical Center, Boston, Massachusetts, USA.
Chen HS; Department of Neurology, General Hospital of Northern Theater Command, Shenyang, China.
Pokaż więcej
Źródło:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Mar; Vol. 30 (3), pp. e14687.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Stroke*/surgery
Stroke*/etiology
Brain Ischemia*/surgery
Brain Ischemia*/etiology
Ischemic Stroke*
Endovascular Procedures*
United States ; Humans ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Inhibition of leukocyte migration after ischemic stroke by VE-cadherin mutation in a mouse model leads to reduced infarct volumes and improved motor skills.
Autorzy:
Koecke MHM; Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.
Strecker JK; Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.
Straeten FA; Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.
Beuker C; Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.
Minnerup J; Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.
Schmidt-Pogoda A; Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.
Pokaż więcej
Źródło:
Brain and behavior [Brain Behav] 2024 Mar; Vol. 14 (3), pp. e3449.
Typ publikacji:
Journal Article
MeSH Terms:
Ischemic Stroke*
Stroke*/genetics
Antigens, CD*
Cadherins*
Mice ; Animals ; Motor Skills ; Leukocytes/physiology ; Infarction ; Mutation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Inflammatory marker profiles and in-hospital neurological deterioration in patients with acute minor ischemic stroke.
Autorzy:
Yi L; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Li ZX; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Jiang YY; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Jiang Y; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Meng X; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Li H; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Zhao XQ; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Wang YL; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Liu LP; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Wang YJ; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Gu HQ; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Mar; Vol. 30 (3), pp. e14648.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Ischemic Stroke*
Stroke*
United States ; Humans ; Female ; Middle Aged ; C-Reactive Protein ; Interleukin-6 ; Hospitals
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clopidogrel with indobufen or aspirin in minor ischemic stroke or high-risk transient ischemic attack: a randomized controlled clinical study.
Autorzy:
Liu X; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Lv X; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Peng Y; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Wang J; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Lei J; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Tang C; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Luo S; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Mai W; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Cai Y; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Fan Q; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Liu C; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Zhang L; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China. .
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2024 Mar 01; Vol. 24 (1), pp. 81. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Ischemic Attack, Transient*/drug therapy
Ischemic Attack, Transient*/epidemiology
Ischemic Stroke*/drug therapy
Stroke*/drug therapy
Phenylbutyrates*
Isoindoles*
Humans ; Aspirin ; Clopidogrel/therapeutic use ; Platelet Aggregation Inhibitors/adverse effects ; Prospective Studies ; Hemorrhage/chemically induced ; Drug Therapy, Combination ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Age and efficacy of remote ischemic conditioning in acute ischemic stroke.
Autorzy:
Cui Y; Department of Neurology, General Hospital of Northern Theater Command, Shenyang, China.
Zhang J; Yinchuan Dingxiang Internet Hospital, Yinchuan, China.
Chen HS; Department of Neurology, General Hospital of Northern Theater Command, Shenyang, China.
Pokaż więcej
Źródło:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Mar; Vol. 30 (3), pp. e14451. Date of Electronic Publication: 2023 Sep 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Ischemic Stroke*
Stroke*/therapy
Humans ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Experience with a hybrid recruitment approach of patient-facing web portal screening and subsequent phone and medical record review for a neurosurgical intervention trial for chronic ischemic stroke disability (PISCES III).
Autorzy:
Kolls BJ; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA. .; Department of Neurology, Duke University School of Medicine, Duke Box 2900 Bryan Research Building, 311 Research Drive, Durham, NC, 27710, USA. .
Muir KW; School of Psychology & Neuroscience, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, Scotland, UK.
Savitz SI; Institute for Stroke and Cerebrovascular Disease, University of Texas Health Science Center, Houston, TX, USA.
Wechsler LR; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Pilitsis JG; Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY, USA.
Rahimi S; Department of Neurosurgery, Medical College of Georgia, Augusta, GA, USA.
Beckman RL; ReNeuron Limited., Pencoed, Bridgend, UK.
Holmes V; ReNeuron Limited., Pencoed, Bridgend, UK.
Chen PR; The Vivian L. Smith Department of Neurosurgery, The University of Texas Health Science Center, Houston, TX, USA.
Albers DS; ReNeuron Limited., Pencoed, Bridgend, UK.
Laskowitz DT; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Neurology, Duke University School of Medicine, Duke Box 2900 Bryan Research Building, 311 Research Drive, Durham, NC, 27710, USA.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Feb 28; Vol. 25 (1), pp. 150. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:
Journal Article
MeSH Terms:
Ischemic Stroke*
Stroke*/diagnosis
Stroke*/therapy
Humans ; Patient Selection ; Research Design ; Medical Records
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
lncRNA-MIAT rs9625066 polymorphism could be a potential biomarker for ischemic stroke.
Autorzy:
Weng YH; Department of Laboratory Medicine, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.; School of Clinical Medicine, Guilin Medical University, Guilin, China.; College of Medical Laboratory Science, Guilin Medical University, Guilin, China.
Chen J; Department of Laboratory Medicine, Affiliated Hospital of Guilin Medical University, Guilin, China.; School of Clinical Medicine, Guilin Medical University, Guilin, China.
Yu WT; School of Clinical Medicine, Guilin Medical University, Guilin, China.
Luo YP; Department of Laboratory Medicine, Affiliated Hospital of Guilin Medical University, Guilin, China.; School of Clinical Medicine, Guilin Medical University, Guilin, China.
Liu C; Department of Laboratory Medicine, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.; School of Clinical Medicine, Guilin Medical University, Guilin, China.; College of Medical Laboratory Science, Guilin Medical University, Guilin, China.
Yang J; Department of Laboratory Medicine, Affiliated Hospital of Guilin Medical University, Guilin, China. .
Liu HB; Department of Laboratory Medicine, The Second Affiliated Hospital of Guilin Medical University, Guilin, China. .; College of Medical Laboratory Science, Guilin Medical University, Guilin, China. .; Guangxi Key Laboratory of Metabolic Reprogramming and Intelligent Medical Engineering for Chronic Diseases, Guangxi Clinical Research Center for Diabetes and Metabolic Diseases, The Second Affiliated Hospital of Guilin Medical University, Guilin, China. .
Pokaż więcej
Źródło:
BMC medical genomics [BMC Med Genomics] 2024 Feb 21; Vol. 17 (1), pp. 58. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:
Journal Article
MeSH Terms:
Ischemic Stroke*/genetics
Myocardial Infarction*
RNA, Long Noncoding*/genetics
Stroke*/genetics
Humans ; Biomarkers ; Genetic Predisposition to Disease ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Association between Brain-Derived Neurotrophic Factor and Lipid Profiles in Acute Ischemic Stroke Patients.
Autorzy:
Tuwar MN; School of Public Health, College of Public Health, Taipei Medical University, Taipei 106236, Taiwan.
Chen WH; Department of Neurology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei 111045, Taiwan.
Yeh HL; Department of Neurology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei 111045, Taiwan.
Bai CH; School of Public Health, College of Public Health, Taipei Medical University, Taipei 106236, Taiwan.; School of Medicine, College of Medicine, Taipei Medical University, Taipei 106236, Taiwan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 17; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 17.
Typ publikacji:
Journal Article
MeSH Terms:
Brain-Derived Neurotrophic Factor*/metabolism
Ischemic Stroke*
Humans ; Cholesterol, HDL ; Cholesterol, LDL ; Triglycerides
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Geographic differences in pharmacotherapy patterns and outcomes of acute ischemic stroke in China.
Autorzy:
Li Y; Department of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, China.; Beijing Key Laboratory of Neurovascular disease discovery, Beijing, China.
Ou Q; Department of medical affairs, Techpool Bio-Pharma Co., LTD, Guangzhou, China.
Lu Y; Department of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, China.; Beijing Key Laboratory of Neurovascular disease discovery, Beijing, China.
Shen Z; Department of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, China.; Beijing Key Laboratory of Neurovascular disease discovery, Beijing, China.
Li J; Department of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, China.; Beijing Key Laboratory of Neurovascular disease discovery, Beijing, China.
Zhang Z; Department of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, China.; Beijing Key Laboratory of Neurovascular disease discovery, Beijing, China.
Tai L; Department of Neurology, Second Hospital of Hebei Medical University, Shijiazhuang, China.
Li G; Department of Neurology, First Affiliated Hospital of Harbin Medical University, Harbin, China.
Chen H; Department of Neurology, General Hospital of Shenyang Military Command, Shenyang, China.
Zhang G; Department of Neurology, Penglai People's Hospital, Penglai, China.
Zhang L; Department of Neurology, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
Sun X; Department of Neurology, Qindao University Medical College Affiliated Yantai Yuhuangding Hospital, Yantai, China.
Qiu J; Department of Neurology, Huizhou First Hospital, Huizhou, China.
Wei Y; Department of Neurology, Harrison International Peace Hospital, Hengshui, China.
Zhu S; Department of Biostatistics, Peking University First Hospital, Beijing, China.
Wang Z; Department of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, China.; Beijing Key Laboratory of Neurovascular disease discovery, Beijing, China.
Sun W; Department of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, China. .; Beijing Key Laboratory of Neurovascular disease discovery, Beijing, China. .
Huang Y; Department of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, China. .; Beijing Key Laboratory of Neurovascular disease discovery, Beijing, China. .
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2024 Feb 15; Vol. 24 (1), pp. 64. Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Brain Ischemia*/drug therapy
Brain Ischemia*/epidemiology
Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use
Ischemic Stroke*/drug therapy
Stroke*/drug therapy
Stroke*/epidemiology
Humans ; Fibrinolytic Agents/therapeutic use ; Platelet Aggregation Inhibitors/therapeutic use ; Thrombolytic Therapy ; Treatment Outcome ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Analysis and identification of oxidative stress-ferroptosis related biomarkers in ischemic stroke.
Autorzy:
Zhang LM; Department of Neurology, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, China.
Liang XL; Department of Emergency, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, China.
Xiong GF; Department of Emergency, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, China.
Xing XL; Department of Emergency, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, China.
Zhang QJ; Department of Emergency, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, China.
Zhang BR; Department of Emergency, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, China.
Liu MW; Department of Emergency, People's Hospital of Dali Bai Autonomous Prefecture, No. 35 Renmin South Road, Xiaguan Street, Dalí, 671000, Yunnan, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 15; Vol. 14 (1), pp. 3803. Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Journal Article
MeSH Terms:
Ferroptosis*/genetics
Ischemic Stroke*
MicroRNAs*/genetics
Humans ; Oxidative Stress/genetics ; Biomarkers ; RNA, Messenger/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cost-effectiveness of edaravone dexborneol versus dl-3-n-butylphthalide for the treatment of acute ischemic stroke: a Chinese health care perspective.
Autorzy:
Li J; Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine，Chinese Academy of Medical Sciences, Beijing Key Laboratory of Assessment of Clinical Drugs Risk and Individual Application (Beijing Hospital), Beijing, China.; Department of Pharmacy Administration and Clinical Pharmacy, Pharmaceutical Science, Peking University, Beijing, China.
Cao W; Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine，Chinese Academy of Medical Sciences, Beijing Key Laboratory of Assessment of Clinical Drugs Risk and Individual Application (Beijing Hospital), Beijing, China.; Department of Pharmacy Administration and Clinical Pharmacy, Pharmaceutical Science, Peking University, Beijing, China.
Zhao F; Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine，Chinese Academy of Medical Sciences, Beijing Key Laboratory of Assessment of Clinical Drugs Risk and Individual Application (Beijing Hospital), Beijing, China.
Jin P; Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine，Chinese Academy of Medical Sciences, Beijing Key Laboratory of Assessment of Clinical Drugs Risk and Individual Application (Beijing Hospital), Beijing, China. .; No. 1 Dahua Road, Dongcheng district, Beijing, 100730, P.R. China. .
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2024 Feb 12; Vol. 24 (1), pp. 436. Date of Electronic Publication: 2024 Feb 12.
Typ publikacji:
Journal Article
MeSH Terms:
Ischemic Stroke*
Stroke*/drug therapy
Benzofurans*
Humans ; Edaravone/therapeutic use ; Cost-Benefit Analysis ; Delivery of Health Care ; Quality-Adjusted Life Years
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The safety and efficacy of intra-arterial low-dose tirofiban administration during endovascular therapy in patients with large ischemic core volume.
Autorzy:
Cho KC; Department of Neurosurgery, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, South Korea.
Son NH; Department of Statistics, Keimyung University, Daegu, South Korea.
Gwon SH; Department of Statistics, Keimyung University, Daegu, South Korea.
Choi JW; Department of Radiology, Ajou University Hospital, Ajou University College of Medicine, 164, World Cup-Ro, Yeongtong-Gu, Suwon, 16499, South Korea.
Jung WS; Department of Radiology, Ajou University Hospital, Ajou University College of Medicine, 164, World Cup-Ro, Yeongtong-Gu, Suwon, 16499, South Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 09; Vol. 14 (1), pp. 3353. Date of Electronic Publication: 2024 Feb 09.
Typ publikacji:
Journal Article
MeSH Terms:
Ischemic Stroke*/etiology
Brain Ischemia*/drug therapy
Stroke*/therapy
Endovascular Procedures*/adverse effects
Humans ; Tirofiban ; Fibrinolytic Agents/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Novel functional insights into ischemic stroke biology provided by the first genome-wide association study of stroke in indigenous Africans.
Autorzy:
Akinyemi RO; Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria.; Center for Genomic and Precision Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.; Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Tiwari HK; Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA.
Srinivasasainagendra V; Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA.
Akpa O; Center for Genomic and Precision Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Sarfo FS; Department of Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Akpalu A; Department of Medicine, University of Ghana Medical School, Accra, Ghana.
Wahab K; Department of Medicine, University of Ilorin Teaching Hospital, Ilorin, Nigeria.
Obiako R; Department of Medicine, Ahmadu Bello University, Zaria, Nigeria.
Komolafe M; Department of Medicine, Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria.
Owolabi L; Department of Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria.
Osaigbovo GO; Jos University Teaching Hospital, Jos, Nigeria.
Mamaeva OA; Department of Epidemiology, School of Public Health University of Alabama at Birmingham, Birmingham, USA.
Halloran BA; Department of Pediatrics, Volker Hall University of Alabama at Birmingham, Birmingham, USA.
Akinyemi J; Department of Epidemiology and Medical Statistics, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Lackland D; Medical University of South Carolina, Charleston, SC, USA.
Obiabo OY; Delta State University/Delta State University Teaching Hospital, Oghara, Nigeria.
Sunmonu T; Department of Medicine, Federal Medical Centre, Ondo State, Owo, Nigeria.
Chukwuonye II; Department of Medicine, Federal Medical Centre Umuahia, Abia State, Umuahia, Nigeria.
Arulogun O; Department of Health Education, Faculty of Public Health, University of Ibadan, Ibadan, Nigeria.
Jenkins C; Medical University of South Carolina, Charleston, SC, USA.
Adeoye A; Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Agunloye A; Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Ogah OS; Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Ogbole G; Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Fakunle A; Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.; Department of Public Health, College of Health Sciences, Osun State University, Osogbo, Nigeria.
Uvere E; Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Coker MM; Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria.; Genetics and Cell Biology Unit, Department of Zoology, Faculty of Science, University of Ibadan, Ibadan, Nigeria.
Okekunle A; Department of Food and Nutrition, Seoul National University, Seoul, South Korea.
Asowata O; Department of Epidemiology and Medical Statistics, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Diala S; Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Ogunronbi M; Department of Medicine, Federal Medical Centre, Abeokuta, Nigeria.
Adeleye O; Department of Medicine, Federal Medical Centre, Abeokuta, Nigeria.
Laryea R; Department of Medicine, University of Ghana Medical School, Accra, Ghana.
Tagge R; Weill Institute for Neurosciences, School of Medicine, University of California San-Francisco, San Francisco, USA.
Adeniyi S; Department of Medicine, University of Ilorin Teaching Hospital, Ilorin, Nigeria.
Adusei N; Department of Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Oguike W; Department of Medicine, Ahmadu Bello University, Zaria, Nigeria.
Olowoyo P; Federal Teaching Hospital, Ido-Ekiti, Ekiti State, Nigeria.
Adebajo O; Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Olalere A; Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Oladele O; Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Yaria J; Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Fawale B; Department of Medicine, Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria.
Ibinaye P; Department of Medicine, Ahmadu Bello University, Zaria, Nigeria.
Oyinloye O; Department of Medicine, Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria.
Mensah Y; Department of Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Oladimeji O; Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Akpalu J; Department of Medicine, University of Ghana Medical School, Accra, Ghana.
Calys-Tagoe B; Department of Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Dambatta HA; Department of Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria.
Ogunniyi A; Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Kalaria R; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
Arnett D; Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, USA.
Rotimi C; Center for Genomics and Global Health, National Human Genome Research Institute, NIH, Bethesda, USA.
Ovbiagele B; Genetics and Cell Biology Unit, Department of Zoology, Faculty of Science, University of Ibadan, Ibadan, Nigeria.
Owolabi MO; Center for Genomic and Precision Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria. .; Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria. .; University College Hospital, Ibadan, Nigeria. .; Lebanese American University of Beirut, Beirut, Lebanon. .; Blossom Specialist Medical Center, Ibadan, Nigeria. .
Pokaż więcej
Corporate Authors:
SIREN Team
Źródło:
Genome medicine [Genome Med] 2024 Feb 05; Vol. 16 (1), pp. 25. Date of Electronic Publication: 2024 Feb 05.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Ischemic Stroke*/complications
Stroke*/genetics
MicroRNAs*
Adult ; Humans ; Genome-Wide Association Study ; Genetic Predisposition to Disease ; Genomics ; Polymorphism, Single Nucleotide ; DNA ; Multicenter Studies as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 21-40 z 72209

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies